Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising ...

Bats’ status as the only truly flying mammals might mean they also have another ‘superpower’ — invincibility to most viruses ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Interferon regulatory factor 3 (IRF3) is a key transcription factor in the type I interferon signaling. Its activation must be tightly controlled to efficiently activate innate immunity while avoiding ...

Recent innovations in DNA-modifying will revolutionize the treatment of many diseases and prompt crucial discussions.

Interferon regulatory factor 3 (IRF3) is a key transcription factor in the type I interferon signaling. Its activation must be tightly controlled to ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

Scientists have identified a new property, interface flexibility, that controls how certain molecules naturally self-organize into crystalline supramolecular networks. This significant discovery could ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Nucleoside analogs are transformative in cancer and antiviral therapies, offering new avenues for treatment despite ...

Large molecules with multiple binding sites can be flexible, but the impact of this flexibility on network formation hasn’t ...